Home
About
Overview
Sharing Data
ORCID
Help
History (32)
Bare Versus Hair: Do Pubic Hair Grooming Preferences Dictate the Urogenital Microbiome?
Glembatumumab vedotin for patients with metastatic, gpNMB overexpressing, triple-negative breast cancer ("METRIC"): a randomized multicenter study.
Activity of XL647 in clinically selected NSCLC patients (pts) enriched for the presence of EGFR mutations: Results from Phase 2.
What Chicago community organizations needed to implement COVID-19 interventions: lessons learned in 2021.
GLORIA: phase III, open-label study of adagloxad simolenin/OBI-821 in patients with high-risk triple-negative breast cancer.
See All 32 Pages
Find People
Find Everything
Edit My Profile
My Person List (
0
)
Return to Top
Login
Username
Password